Pernix Therapeutics (PTX) Bullish Stance Reiterated at Needham & Company
Tweet Send to a Friend
Needham & Company analsyt Elliot Wilbur reiterated a Buy rating and $5 price target on Pernix Therapeutics (NASDAQ: PTX) following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
